Volume 95 Issue 45 | pp. 24-26
Issue Date: November 13, 2017

Growth strategies for pharmaceutical chemical makers on display at CPhI

Frankfurt expo showcases a transformation in contract R&D and manufacturing of drug ingredients
Department: Business
Keywords: Outsourcing, active pharmaceutical ingredient, fine chemicals, pharmaceuticals, biologics, China

The pharmaceutical chemical sector is experiencing a prolonged period of profitability and a wave of transformation as companies invest profits in new ventures and new capacity. A picture of how the sector is evolving came into focus last month when CPhI Worldwide, the annual pharmaceutical ingredients exhibition, came to Frankfurt.

The event­—the largest of its kind in the world, attended by more than 40,000 people—followed a year and a half of robust merger and acquisition . . .

To view the rest of this content, please log in with your ACS ID.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society